Vardenafil hydrochloride trihydrate
(FBCDRHDULQYRTB-UHFFFAOYSA-N)
Structure
- SMILES
- CCOc1ccc(cc1c1[nH]c(=O)c2n(n1)c(CCC)nc2C)S(=O)(=O)N1CCN(CC1)CC.O.O.O.Cl
- Molecular Formula:
- C23H39ClN6O7S
- Molecular Weight:
- 579.110
- Log P:
- 3.6361
- Hydrogen Bond Acceptor:
- 12
- Hydrogen Bond Donor:
- 5
- TPSA:
- 148.97
- CAS Number(s):
- 330808-88-3
Synonym(s)
1.
Vardenafil hydrochloride trihydrate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 34 | US FAERS | |
| 2 | Erectile dysfunction | FAERS: 18 | US FAERS | |
| 3 | Headache | FAERS: 9 | US FAERS | |
| 4 | Dizziness | FAERS: 7 | US FAERS | |
| 5 | Drug administration error | FAERS: 7 | US FAERS | |
| 6 | Nausea | FAERS: 5 | US FAERS | |
| 7 | No adverse event | FAERS: 5 | US FAERS | |
| 8 | Product use issue | FAERS: 5 | US FAERS | |
| 9 | Dysgeusia | FAERS: 4 | US FAERS | |
| 10 | Expired product administered | FAERS: 4 | US FAERS | |
| 11 | Drug dispensing error | FAERS: 3 | US FAERS | |
| 12 | Back Pain | FAERS: 2 | US FAERS | |
| 13 | Chest Pain | FAERS: 2 | US FAERS | |
| 14 | Extra dose administered | FAERS: 2 | US FAERS | |
| 15 | Flushing | FAERS: 2 | US FAERS | |
| 16 | Incorrect route of drug administration | FAERS: 2 | US FAERS | |
| 17 | Intentional product use issue | FAERS: 2 | US FAERS | |
| 18 | Product physical issue | FAERS: 2 | US FAERS | |
| 19 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 20 | Anger | FAERS: 1 | US FAERS | |
| 21 | Anorgasmia | FAERS: 1 | US FAERS | |
| 22 | Blood testosterone decreased | FAERS: 1 | US FAERS | |
| 23 | Burning sensation | FAERS: 1 | US FAERS | |
| 24 | Chest discomfort | FAERS: 1 | US FAERS | |
| 25 | Constipation | FAERS: 1 | US FAERS | |
| 26 | Deafness | FAERS: 1 | US FAERS | |
| 27 | Device use error | FAERS: 1 | US FAERS | |
| 28 | Drug administered at inappropriate site | FAERS: 1 | US FAERS | |
| 29 | Drug effect faster than expected | FAERS: 1 | US FAERS | |
| 30 | Erythema | FAERS: 1 | US FAERS | |
| 31 | Exposure via partner | FAERS: 1 | US FAERS | |
| 32 | Eye pain | FAERS: 1 | US FAERS | |
| 33 | Fatigue | FAERS: 1 | US FAERS | |
| 34 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 35 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 36 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 37 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 38 | Oral pain | FAERS: 1 | US FAERS | |
| 39 | Overdose | FAERS: 1 | US FAERS | |
| 40 | Product adhesion issue | FAERS: 1 | US FAERS | |
| 41 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 42 | Product quality issue | FAERS: 1 | US FAERS | |
| 43 | Product selection error | FAERS: 1 | US FAERS | |
| 44 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 45 | Pruritus | FAERS: 1 | US FAERS | |
| 46 | Sluggishness | FAERS: 1 | US FAERS | |
| 47 | Spontaneous penile erection | FAERS: 1 | US FAERS | |
| 48 | Stomatitis | FAERS: 1 | US FAERS | |
| 49 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 50 | Tinnitus | FAERS: 1 | US FAERS | |
| 51 | Urticaria | FAERS: 1 | US FAERS | |
| 52 | Victim of sexual abuse | FAERS: 1 | US FAERS | |
| 53 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 54 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 55 | Creatinine renal clearance decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 56 | Dysphonia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.